Pfizer continues delivering consistent earnings beats, driven by cost-cutting initiatives and improving margins. Learn more ...

The latest trading day saw Pfizer (PFE) settling at $26.8, representing a -1.87% change from its previous close.

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Pfizer (PFE) stock is in focus as executive Andrew Baum, who joined the company in 2024 as the Chief Strategy and Innovation ...

Pfizer (PFE) recently reported a revenue decline tied to weaker COVID product sales and a US$4.4b impairment charge, while ...

Barclays analyst Emily Field maintained a Sell rating on Pfizer today and set a price target of $25.00. Claim 30% Off TipRanks. Unlock hedge fund-level data and powerful investing ...

Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks for beginners to invest in. CICC initiated coverage of Pfizer Inc.

View Pfizer Inc. PFE stock quote prices, financial information, real-time forecasts, and company news from CNN.

Pfizer (PFE) closed the most recent trading day at $27.34, moving +1.56% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 1.02%. Meanwhile, the Dow ...

Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the August 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options ...

Pfizer Inc. (NYSE:PFE) will release earnings results for the third quarter before the opening bell on Tuesday, Nov. 4. Analysts expect the health care company to report quarterly earnings at 64 cents ...